Search

Author/Creator Horne, Heather

1. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015)

Authors:
Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le...
Journal:
European journal of cancer
Issue:
Volume 51:Issue 14(2015:Sep.)
Page Start:
1857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015)

Authors:
Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le...
Journal:
European journal of cancer
Issue:
Volume 51:Issue 14(2015:Sep.)
Page Start:
1857
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Low‐dose anti‐CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. (6th July 2013)

Authors:
Liebman, Howard A.; Saleh, Mansoor N.; Bussel, James B.; Negrea, Ovidiu George; Horne, Heather; Wegener, William A.; Goldenberg, David M.
Journal:
British journal of haematology
Issue:
Volume 162:Number 5(2013:Sep.)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase I, multicentre, dose‐escalation trial of monotherapy with milatuzumab (humanized anti‐CD74 monoclonal antibody) in relapsed or refractory multiple myeloma. (25th September 2013)

Authors:
Kaufman, Jonathan L.; Niesvizky, Ruben; Stadtmauer, Edward A.; Chanan‐Khan, Asher; Siegel, David; Horne, Heather; Wegener, William A.; Goldenberg, David M.
Journal:
British journal of haematology
Issue:
Volume 163:Number 4(2013:Nov.)
Page Start:
478
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia*. Issue 4 (2nd April 2016)

Authors:
Kalaycio, Matt E.; George Negrea, O.; Allen, Steven L.; Rai, Kanti R.; Abbasi, Rashid M.; Horne, Heather; Wegener, William A.; Goldenberg, David M.
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 4(2016:Apr.)
Page Start:
803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗